Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionTruist Financial Corp
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Truist Financial Corp closes position in DLB / Dolby Laboratories, Inc.

On April 27, 2026 - Truist Financial Corp filed a 13F-HR form disclosing ownership of 0 shares of Dolby Laboratories, Inc. (US:DLB) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 8,076 shares of Dolby Laboratories, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 0 -100.00 0
2026-02-02 2025-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 8,076 -2,587 -24.26 519 -32.81 0.0007
2025-11-03 2025-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 10,663 -952 -8.20 772 -10.56 0.0010
2025-07-18 2025-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 11,615 -888 -7.10 863 -14.14 0.0013
2025-04-29 2025-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 12,503 6,322 102.28 1,004 108.30 0.0016
2025-01-31 2024-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 6,181 -1,046 -14.47 483 -12.84 0.0008
2024-11-13 2024-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 7,227 -61,154 -89.43 553 -89.79 0.0009
2024-08-21 2024-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 68,381 -6,725 -8.95 5,418 -13.89 0.0082
2024-05-13 2024-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 75,106 -1,286 -1.68 6,292 -4.44 0.0095
2024-02-02 2023-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 76,392 2,306 3.11 6,583 12.11 0.0105
2023-11-14 2023-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 74,086 3,917 5.58 5,872 0.02 0.0098
2023-08-01 2023-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 70,169 681 0.98 5,872 -1.08 0.0098
2023-05-05 2023-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 69,488 2,830 4.25 5,936 26.22 0.0102
2023-02-17 2022-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 66,658 17,817 36.48 4,702 47.82 0.0083
2022-10-26 2022-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 48,841 6,489 15.32 3,181 4.95 0.0061
2022-07-22 2022-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 42,352 34,977 474.26 3,031 425.30 0.0056
2022-04-22 2022-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 7,375 459 6.64 577 -12.44 0.0009
2022-02-14 2021-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 6,916 -964 -12.23 659 -5.04 0.0010
2021-11-05 2021-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 7,880 601 8.26 694 -3.07 0.0011
2021-08-16 2021-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 7,279 240 3.41 716 3.02 0.0012
2021-05-17 2021-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 7,039 461 7.01 695 8.76 0.0012
2021-11-19 2020-12-31 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 6,578 -779 -10.59 639 30.94 0.0012
2021-02-18 2020-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 13,013 5,656 1,264 0.0023
2021-11-05 2020-09-30 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 7,357 -730 -9.03 488 -8.44 0.0011
2020-11-13 2020-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 7,357 -730 488 0.0011
2021-11-16 2020-06-30 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 8,087 13 0.16 533 21.97 0.0012
2020-08-14 2020-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 8,087 13 533 0.0012
2021-11-05 2020-03-31 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 8,074 -987 -10.89 437 -29.97 0.0012
2020-05-15 2020-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 8,074 -987 437 0.0011
2021-11-16 2019-12-31 13F/A-1 DOLBY LABORATORIES COM CL A 25659T107 9,061 9,061 624 0.0013
2020-02-14 2019-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 9,061 624 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.